AI4HOPE Dementia Care Planning Pilot Study 2 ( AI4HOPE2) — AI4HOPE-P2  

Dementia Clinical Trial

Official title: AI4HOPE - Artificial Intelligence Based Health, Optimism, Purpose, and Endurance in Palliative Care Ofr Dementia: Pilot Study 2 Digital Dementia Care Planning

Status Not yet recruiting

Clinical Trial Summary

This pilot study will test a digital care planning decision support system for patients with dementia.

Clinical Trial Description

he clinical study is part of an EU-funded project on the use of artificial intelligence for patients with dementia. This study will test a digital toolkit for advance care planning and decision making for patients with dementia and pilot-test this digital support system for feasibility and acceptability.

Other workpackages of the AI4HOPE project will design a digital technology platform to provide relevant, timely and appropriate information for people with dementia and their carers, and to facilitate them to document their goals, wishes, and preferences for future care.

Patients with mild to moderate dementia will be recruited for the pilot study in the six participating countries. The study population includes all types of dementia without stratification, as the aim of the study is to develop a digital technology platform to facilitate ACP for clinical practice in any patient with cognitive impairment from any type of dementia.

Even though the digital platform could be adapted to be useful for patients with advanced dementia and more severe cognitive impairment, or for use just by their families, the pilot study will recruit only patients with mild or moderate dementia, who will still be able to provide informed consent, and who will be able to self-assess for patient-related outcome or patient-related experience measures to inform the assessment of the digital technology platform.

Patients with dementia treated in the participating study centers will be screened for inclusion criteria and, if suitable will be invited to participate. The study will be performed for up to 90 days, with optional extension to 180 days according to patients' preferences.

Patients with baseline data and at least one interaction with the digital platform and data completed before and after that interaction will be included in the evaluation. ;

Related Conditions & MeSH terms

• Dementia

• NCT number: NCT06292143
• Study type: Interventional
• Source: University of Bonn
• Contact: Lukas Radbruch, MD
• Phone: +4915158233747
• Email: lukas.radbruch@ukbonn.de
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2025
• Completion date: December 2026